Abstract

The project is involved in the analytical assessment of bulk drug substances and clinical drug products of anti-tumor drug candidates. Physical and chemical data provided in the study reports will be submitted as part of the Investigational New Drug (IND) filing required for clinical studies of potential anti-tumor agents.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Resource and Support Contracts (N02)
Project #
261201200028C-3-0-1
Application #
8655049
Study Section
Project Start
2012-08-01
Project End
2017-07-31
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$104,595
Indirect Cost

  Institution

Name
Sri International
Department
Type
DUNS #
009232752
City
Menlo Park
State
CA
Country
United States
Zip Code
94025